Climara
Climara is generically known as Estradiol Transdermal. Generally, estradiol maximizes the chances of developing endometrial hyperplasia, which is a condition known to cause cancer of the uterus. Your health care provider, suggests you to take progestin while being on treatment with Climara in case your uterus is not removed.
This medication should not be used, if any of the following conditions exists in a woman who is on treatment with Climara: vaginal bleeding problem, breast cancer or uterine cancer, normal bleeding disorder and etc.
Warnings associated with Climara
• Pregnant women should not use this medication.
• A patient who is of age less than 18 years should not use it.
• While being on treatment for other disorders, consult your healthcare provider before using this medication.
• This is a prescription medication, which can be procured either through over the counter pharmacies or through online pharmacies.
• This medication should not be used while you are breast-feeding your newborn baby. Because estradiol, an effective estrogen may pass into the breast milk and can harm your newborn baby.
• Keep this medication away from heat and moisture.
Climara is used for the treatment of certain symptoms of menopause in women such as burning, itching and dryness of the vaginal area. It minimizes the urgency of urination and also used widely to treat ovarian disorders, abnormal vaginal bleeding and infertility. Climara sometimes prevents postmenopausal osteoporosis.
Before using Climara, you need to discuss with your healthcare provider if you have: high blood pressure or heart disease; liver disease; asthma; high cholesterol or triglycerides; kidney disease; epilepsy or other seizure disorder; depression; migraines; diabetes; gallbladder disease; or in case you have removed your uterus
(hysterectomy).
Usage of Climara
• Use this medication as prescribed by the doctor. Do not use in larger amounts or for longer days than suggested. Before using go through the instructions on the prescription label.
• Apply it to a clean and dry skin. Try to avoid using this medication on oil and damaged skin.
• Stretch the patch clearly on the skin and press it for around 10 seconds particularly around the edges.
• If the climara skin patch falls down, then try keeping it on some other location on your body.
• If you miss any particular patch, leave it off and apply it on the next scheduled period. Don’t overdose for the missed dosage.
• If any symptoms arising on using this skin patch, immediately remove it and
contact your doctor for treatment.
CLIMARA NEWS HIGHLIGHTS
- New Screening Catches More Breast Cancers
(HealthDay) - FDA approves anti-nausea patch for chemo patients
(AP) - FDA approves anti-nausea patch for chemo patients
(AP) - Breast Cancer Vaccine Blasts Some Tumors
(HealthDay) - Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer
(HealthDay) - Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer
(HealthDay) - Coffee may lower endometrial cancer risk
(Reuters) - Coffee may lower endometrial cancer risk
(Reuters) - Coffee may lower endometrial cancer risk
(Reuters) - Coffee may lower endometrial cancer risk
(Reuters) - Kids, Adults React Equally to Allergy Patch Tests
(HealthDay) - Kids, Adults React Equally to Allergy Patch Tests
(HealthDay) - Kids, Adults React Equally to Allergy Patch Tests
(HealthDay) - Kids, Adults React Equally to Allergy Patch Tests
(HealthDay) - Male hormone patch increases libido in women
(Reuters) - Male hormone patch increases libido in women
(Reuters) - Drug Could Help Treat Small HER2-Positive Breast Tumors
(HealthDay) - Family history can trump breast cancer gene test
(AP) - Family history can trump breast cancer gene test
(AP) - Family history can trump breast cancer gene test
(AP) - Celebrex Might Thwart Inherited Skin Cancers
(HealthDay) - Celebrex Might Thwart Inherited Skin Cancers
(HealthDay) - Celebrex Might Thwart Inherited Skin Cancers
(HealthDay) - Celebrex Might Thwart Inherited Skin Cancers
(HealthDay) - Pregnancy possible after fibroid treatment
(Reuters) - New guidelines back mammograms starting at age 40
(Reuters) - New guidelines back mammograms starting at age 40
(Reuters) - Mammograms lagging in women after childhood cancer
(Reuters) - Study may guide preventive mastectomy decision
(Reuters) - Study may guide preventive mastectomy decision
(Reuters) - Ovarian surgery doesn’t end all cancer risk: study
(Reuters) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Few Women at High Risk for Breast Cancer Take Tamoxifen
(HealthDay) - Few Women at High Risk for Breast Cancer Take Tamoxifen
(HealthDay) - How to help patients make wiser health choices
(AP) - Many risks seen with traumatic brain injury
(Reuters) - Many risks seen with traumatic brain injury
(Reuters) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer
Patients
(HealthDay) - FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
- FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
- Estrogen patch shows promise for prostate cancer
- Joint Symptoms More Likely For Some Breast Cancer Patients
- Breast cancer recurrence seen as low after 5 years